Stock · NSE
ZYDUSLIFE
1,150.80▼ 8.20 (-0.71%)Last 2 days · 15m candles10/7/2026, 22:31:13
Open: 1,162.00High: 1,162.00Low: 1,147.80Prev: 1,159.00
News mentioning ZYDUSLIFE
VERIFIEDET Stocks·3d★ ON YOUR LIST
Sumitomo Chemical among 4 stocks that closed crossing below VWAPAI summary· NEGATIVE
- ·Four Nifty500 stocks, including Sumitomo Chemical India, closed over 1.5% below their VWAP on July 6.
- ·Zydus Wellness, Max Healthcare Institute, and Zensar Technologies were also among these stocks.
- ·This indicates potential bearish momentum and increased selling pressure.
VERIFIEDMint Companies·4d★ ON YOUR LIST
True North cashes out $2 billion for investors as PE firms step up exitsAI summary· POSITIVE
- ·True North has returned $2 billion to investors.
- ·This return is attributed to exits from several portfolio companies.
- ·Exited companies include FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness, and Home First Finance.
Google News, NIFTY/SENSEX·4d★ ON YOUR LIST
Nifty outlook: Buy the dips, says Angel One; likes IndusInd Bk, Zydus Life - Business StandardVERIFIEDET Finance·7d★ ON YOUR LIST
Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testAI summary· NEUTRAL
- ·Zydus Lifesciences has partnered with Apollo Hospitals to launch the Shield multi-cancer detection test in India.
- ·The blood test, developed with Guardant Health, can detect signals for multiple cancer types.
- ·The test is available for individuals aged 45 and above, aiming to improve early cancer detection.
Google News, NIFTY/SENSEX·7d★ ON YOUR LIST
HCL Tech, Zydus Life, Marico among buzzing stocks as SENSEX jumps over 500 pts, NIFTY50 up 0.8% in noon deals - UpstoxVERIFIEDET Markets·11d★ ON YOUR LIST
Market Trading Guide: Finolex Cables among 2 stock recommendations for TuesdayAI summary· POSITIVE
- ·Domestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal.
- ·Analysts recommend buying Finolex Cables.
- ·Analysts recommend buying Zydus Wellness, citing bullish technical setups, strong moving-average support and breakout patterns with upside potential.
VERIFIEDET Stocks·11d★ ON YOUR LIST
Market Trading Guide: Finolex Cables among 2 stock recommendations for TuesdayAI summary· POSITIVE
- ·Domestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal.
- ·Analysts recommend buying Finolex Cables.
- ·Analysts recommend buying Zydus Wellness, citing bullish technical setups, strong moving-average support and breakout patterns with upside potential.
VERIFIEDET Finance·14d★ ON YOUR LIST
Zydus, Sunshine to set up $20 million pharma JV in Sri LankaAI summary· POSITIVE
- ·Zydus Lifesciences and Sunshine Healthcare Lanka will form a $20 million joint venture.
- ·The new entity, Zydus Sunshine Lifesciences, will establish a manufacturing facility in Sri Lanka's Horana Export Processing Zone.
- ·The venture aims to increase local drug production and reduce import dependency.
VERIFIEDET Finance·17d★ ON YOUR LIST
Indian pharma firms gear up to supply key cancer drug to USAI summary· NEUTRAL
- ·Indian drugmakers are preparing to supply ifosfamide injection to the US.
- ·Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to provide the chemotherapy drug.
- ·The US FDA has contacted Indian pharmaceutical bodies to find manufacturers for the drug.
Google News, India stocks·22d★ ON YOUR LIST
Zydus Completes Major Overseas Acquisition Deal | Jaiprakash Associates to be Delisted from Stock Exchanges | Top Buzzing Stocks Today - EquitymasterVERIFIEDET Stocks·23d★ ON YOUR LIST
Zydus Lifesciences shares in focus as firm acquires US-based Assertio Holdings for $166 millionVERIFIEDET Finance·24d★ ON YOUR LIST
Zydus Lifesciences completes acquisition of AssertioAI summary· NEUTRAL
- ·Zydus Lifesciences has completed the acquisition of Assertio Holdings Inc.
- ·The acquisition was made through its wholly-owned subsidiary, Zara Merger Sub Inc.
- ·The transaction involved a cash tender offer for all outstanding shares of Assertio's common stock.
VERIFIEDET Stocks·30d★ ON YOUR LIST
Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a monthVERIFIEDET Markets·30d★ ON YOUR LIST
Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a monthVERIFIEDET Stocks·30d★ ON YOUR LIST
Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?VERIFIEDET Markets·30d★ ON YOUR LIST
Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?VERIFIEDET Finance·37d★ ON YOUR LIST
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsAI summary· NEUTRAL
- ·The Delhi High Court has directed the CDSCO to review a petition against Zydus Lifesciences' semaglutide injection approval.
- ·A diabetes patient has raised concerns regarding the drug's delivery system, citing potential health risks.
- ·The CDSCO is required to make a decision on the patient's representation within two months.
VERIFIEDMint Markets·38d★ ON YOUR LIST
Zydus Lifesciences share buyback to open on 4 June: Should you participate or not?AI summary· NEUTRAL
- ·Zydus Lifesciences share buyback is set to open on June 4.
- ·The company's stock was trading 2.5% lower at ₹1,063 per share on June 2.
- ·Experts are offering opinions on retail investor participation in the buyback.
VERIFIEDMint Markets·42d★ ON YOUR LIST
Stocks to watch: Zydus Life, IndiGo, RIL among 10 shares in focus today; check list hereAI summary· NEUTRAL
- ·The Sensex declined 142 points, or 0.19%, to close at 75,867.80 on Wednesday.
- ·The Nifty 50 slipped 7 points, or 0.03%, to settle at 23,907.15.
- ·Zydus Life, IndiGo, and RIL are among 10 shares in focus for May 29.
Google News, India stocks·42d★ ON YOUR LIST
Stocks to watch: Zydus Life, IndiGo, RIL among 10 shares in focus today; check list here - MintVERIFIEDET Stocks·42d★ ON YOUR LIST
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCAI summary· NEUTRAL
- ·Reliance Industries announced its AGM for June 19, 2026.
- ·Coal India's government offer-for-sale will exercise the oversubscription option.
- ·Bharat Dynamics reported a 58.5% YoY drop in Q4 FY26 net profit.
VERIFIEDET Markets·42d★ ON YOUR LIST
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCAI summary· NEUTRAL
- ·Reliance Industries announced its AGM for June 19, 2026.
- ·Coal India's government offer-for-sale will exercise the oversubscription option.
- ·Bharat Dynamics reported a 58.5% YoY drop in Q4 FY26 net profit.
VERIFIEDET Finance·43d★ ON YOUR LIST
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAAI summary· POSITIVE
- ·Zydus Therapeutics' drug saroglitazar has received priority review from the US FDA.
- ·The drug is intended for the treatment of primary biliary cholangitis, a liver disease.
- ·Zydus Therapeutics plans to launch saroglitazar in the US in the fourth quarter of fiscal year 2027.
VERIFIEDMint Markets·43d★ ON YOUR LIST
Zydus Lifesciences raises share buyback price, cuts share count. Details hereAI summary· NEUTRAL
- ·Zydus Lifesciences has increased its share buyback price.
- ·The company has also reduced the number of shares offered in the buyback.
- ·Revised details of the offer have been announced.
VERIFIEDET Stocks·44d★ ON YOUR LIST
Zydus Lifesciences hikes share buyback price to Rs 1,260 per share, lowers share countAI summary· NEUTRAL
- ·Zydus Lifesciences has raised its share buyback price to Rs 1,260 per share.
- ·The company has reduced the number of shares to be repurchased to 87.3 lakh shares.
- ·The total outlay for the buyback remains Rs 1,100 crore.
VERIFIEDET Markets·44d★ ON YOUR LIST
Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumAI summary· POSITIVE
- ·Zydus Lifesciences will buy back up to 95.65 lakh shares at Rs 1,150 each.
- ·The buyback is valued at Rs 1,100 crore and offers a 7% premium.
- ·Investors must purchase shares by May 27 to be eligible for the May 29 record date.
VERIFIEDET Stocks·44d★ ON YOUR LIST
Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumAI summary· POSITIVE
- ·Zydus Lifesciences will buy back up to 95.65 lakh shares at Rs 1,150 each.
- ·The buyback is valued at Rs 1,100 crore and offers a 7% premium.
- ·Investors must purchase shares by May 27 to be eligible for the May 29 record date.
VERIFIEDET Markets·47d★ ON YOUR LIST
6 pharma stocks that Bernstein sees up to 40% upside potential. Do you own any?AI summary· POSITIVE
- ·Bernstein initiated coverage on six pharmaceutical stocks.
- ·The brokerage cited AI, innovation, and a strengthening ecosystem as drivers for the Indian healthcare sector.
- ·Zydus Lifesciences was named as the top pick with significant upside potential.
VERIFIEDET Stocks·47d★ ON YOUR LIST
6 pharma stocks that Bernstein sees up to 40% upside potential. Do you own any?AI summary· POSITIVE
- ·Bernstein initiated coverage on six pharmaceutical stocks.
- ·The brokerage cited AI, innovation, and a strengthening ecosystem as drivers for the Indian healthcare sector.
- ·Zydus Lifesciences was named as the top pick with significant upside potential.
VERIFIEDET Finance·47d★ ON YOUR LIST
Sakar Healthcare partners with Zydus Lifesciences for GCC MarketsAI summary· NEUTRAL
- ·Sakar Healthcare has entered into a partnership with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets.
- ·This agreement represents Sakar Healthcare's 40th global collaboration in the anti-cancer product segment.
- ·The company is actively pursuing regulatory filings and approvals in highly regulated international markets.